How Mazzo was paid
$1.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Other | Total |
|---|---|---|---|---|---|
| David J. MazzoChief Executive Officer | $711,729 | $307,800 | $104,080 | $23,750 | $1,147,359 |
| Kristen K. Buck, M.D.Former Executive Vice President R&D and Chief Medical Officer | $599,342 | $95,000 | $33,826 | $8,250 | $736,418 |
| James NiscoSenior Vice President, Finance and Treasury and Chief Accounting Officer | $350,000 | $57,000 | $18,214 | $8,250 | $433,464 |
What changed and why
- $1.1M2025 CEO total compensation was $1,147,359, versus $1,691,174 in 2024.
- $388K2025 CEO bonus was $—; Dr. Mazzo received a $387,876 bonus in 2024.
- 55%Dr. Mazzo’s target annual bonus is 55% of base salary, with a maximum of 100%.
- $308K2025 CEO stock awards were $307,800 and option awards were $104,080.
- $179K2024 CEO stock awards included performance stock units valued at $178,640; performance criteria were met in 2024.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.